Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery

BACKGROUND: Proteins that ‘read’ the histone code are central elements in epigenetic control and bromodomains, which bind acetyl-lysine motifs, are increasingly recognized as potential mediators of disease states. Notably, the first BET bromodomain-based therapies have entered clinical trials and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Yanai, Kost-Alimova, Maria, Shi, Xi, Leo, Elisabetta, Bardenhagen, Jennifer P., Shepard, Hannah E., Appikonda, Srikanth, Vangamudi, Bhavatarini, Zhao, Shuping, Tieu, Trang N., Jiang, Shiming, Heffernan, Timothy P., Marszalek, Joseph R., Toniatti, Carlo, Draetta, Giulio, Tyler, Jessica, Barton, Michelle, Jones, Philip, Palmer, Wylie S., Geck Do, Mary K., Andersen, Jannik N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578755/
https://www.ncbi.nlm.nih.gov/pubmed/26396593
http://dx.doi.org/10.1186/s13072-015-0026-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578755/
https://www.ncbi.nlm.nih.gov/pubmed/26396593
http://dx.doi.org/10.1186/s13072-015-0026-4

Ejemplares similares